Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Tertiary Lymphoid Structures × relatlimab × 90 days × Clear all

Sponsor

Conditions

Melanoma 9 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasm Metastasis 2 Uveal Melanoma 1 Turcot syndrome 1 Skin Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms by Site 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Microsatellite Instability 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Hodgkin Disease 1 Glioblastoma 1 Gastroesophageal Cancer 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1

Interventions

tazemetostat 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡